Insider Transactions in Q1 2023 at Enfusion, Inc. (ENFN)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 24
2023
|
Tarek Hammoud > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,000,000
+49.99%
|
-
|
Mar 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,877
-4.31%
|
$38,770
$10.94 P/Share
|
Mar 08
2023
|
Tarek Hammoud > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,870,000
-76.71%
|
$18,700,000
$10.9 P/Share
|
Mar 08
2023
|
Stephen Malherbe > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-100.0%
|
$11,000,000
$11.35 P/Share
|
Feb 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,877
-4.14%
|
$38,770
$10.93 P/Share
|
Feb 16
2023
|
Stephen Malherbe > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,000,000
+50.0%
|
-
|
Jan 25
2023
|
Steven M. Bachert Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,632
-4.82%
|
$105,952
$11.88 P/Share
|
Jan 25
2023
|
Steven M. Bachert Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,739
+15.16%
|
-
|
Jan 25
2023
|
Bronwen Bastone Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.13%
|
$2,398
$11.88 P/Share
|
Jan 25
2023
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
638
+0.39%
|
-
|
Jan 25
2023
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,238
+10.04%
|
-
|
Jan 25
2023
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,219
-8.95%
|
$101,409
$11.88 P/Share
|
Jan 25
2023
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,976
+17.59%
|
-
|
Jan 25
2023
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.39%
|
$2,024
$11.88 P/Share
|
Jan 25
2023
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
483
+1.02%
|
-
|
Jan 23
2023
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,382
-6.82%
|
$40,584
$12.05 P/Share
|
Jan 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,877
-4.57%
|
$38,770
$10.93 P/Share
|
Jan 10
2023
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,190
-27.5%
|
$354,090
$11.26 P/Share
|
Jan 09
2023
|
Michael Spellacy Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,341
+32.8%
|
-
|
Jan 09
2023
|
Deirdre Somers Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,313
+34.13%
|
-
|
Jan 05
2023
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,651
+4.61%
|
-
|
Jan 05
2023
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,521
+8.35%
|
-
|
Jan 05
2023
|
Oleg Movchan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,604
+7.66%
|
-
|
Jan 05
2023
|
Bradley Herring Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,688
+15.87%
|
-
|
Jan 05
2023
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,651
+3.35%
|
-
|